Multiparametric Analyses of Human PBMCs Loaded Ex Vivo with a Candidate Idiotype Vaccine for HCV-Related Lymphoproliferative Disorders

• Annacarmen Petrizzo,

  Affiliation Laboratory of Molecular Biology and Viral Oncogenesis, National Cancer Institute “Fond. G. Pascale”, Naples, Italy

  ⨯
• Maria Lina Tornesello,

  Affiliation Laboratory of Molecular Biology and Viral Oncogenesis, National Cancer Institute “Fond. G. Pascale”, Naples, Italy

  ⨯
• Maria Napolitano,

  Affiliation Laboratory of Clinical Immunology, National Cancer Institute “Fond. G. Pascale”, Naples, Italy

  ⨯
• Giovanna D'Alessio,

  Affiliation Division of Infectious Diseases, Rummo Hospital, Benevento, Italy

  ⨯
• Angelo Salomone Megna,

  Affiliation Division of Infectious Diseases, Rummo Hospital, Benevento, Italy

  ⨯
• Riccardo Dolcetti,

  Affiliation Cancer Bio-Immunotherapy Unit, Centro di Riferimento Oncologico, National Cancer Institute, Aviano, Italy

  ⨯
• Valli De Re,

  Affiliation Experimental and Clinical Pharmacology, Centro di Riferimento Oncologico, National Cancer Institute, Aviano, Italy

  ⨯
• Ena Wang,

  Affiliation Infectious Disease and Immunogenetics Section (IDIS), Department of Transfusion Medicine, Clinical Center, and trans-NIH Center for Human Immunology, National Institutes of Health, Bethesda, Maryland, United States of America

  ⨯
• Franco M. Marincola,

  Affiliation Infectious Disease and Immunogenetics Section (IDIS), Department of Transfusion Medicine, Clinical Center, and trans-NIH Center for Human Immunology, National Institutes of Health, Bethesda, Maryland, United States of America

  ⨯
• Franco M. Buonaguro,

  Affiliation Laboratory of Molecular Biology and Viral Oncogenesis, National Cancer Institute “Fond. G. Pascale”, Naples, Italy

  ⨯
• Luigi Buonaguro

  * E-mail: l.buonaguro@istitutotumori.na.it

  Affiliation Laboratory of Molecular Biology and Viral Oncogenesis, National Cancer Institute “Fond. G. Pascale”, Naples, Italy

  ⨯